Filing Details

Accession Number:
0002001011-24-000088
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-24 19:41:37
Reporting Period:
2024-09-20
Accepted Time:
2024-09-24 19:41:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
886163 Ligand Pharmaceuticals Inc LGND Pharmaceutical Preparations (2834) 770160744
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1905248 Octavio Espinoza 555 Heritage Drive
Suite 200
Jupiter FL 33458
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-09-20 200 $103.98 25,685 No 4 S Direct
Common Stock Disposition 2024-09-20 275 $103.86 25,410 No 4 S Direct
Common Stock Disposition 2024-09-20 800 $103.95 24,610 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct